{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T00:40:14Z","timestamp":1794271214704,"version":"4.9.0"},"reference-count":148,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T00:00:00Z","timestamp":1751587200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T00:00:00Z","timestamp":1751587200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s12035-025-05177-w","type":"journal-article","created":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T21:37:04Z","timestamp":1751578624000},"page":"15318-15335","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["PET Imaging Unveils Neuroinflammatory Mechanisms in Psychiatric Disorders: From Microglial Activation to Therapeutic Innovation"],"prefix":"10.1007","volume":"62","author":[{"given":"Yu-dan","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-heng","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue-ting","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-yao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao-yan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei-chen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-min","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,4]]},"reference":[{"key":"5177_CR1","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.apsb.2020.08.006","volume":"11","author":"L Zhang","year":"2021","unstructured":"Zhang L, Hu K, Shao T, Hou L, Zhang S, Ye W et al (2021) Recent developments on PET radiotracers for TSPO and their applications in neuroimaging. Acta Pharm Sin B 11:373\u2013393","journal-title":"Acta Pharm Sin B"},{"key":"5177_CR2","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.neuron.2020.06.002","volume":"107","author":"E Beurel","year":"2020","unstructured":"Beurel E, Toups M, Nemeroff CB (2020) The bidirectional relationship of depression and inflammation: double trouble. Neuron 107:234\u2013256","journal-title":"Neuron"},{"key":"5177_CR3","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1146\/annurev.immunol.021908.132528","volume":"27","author":"RM Ransohoff","year":"2009","unstructured":"Ransohoff RM, Perry VH (2009) Microglial physiology: unique stimuli, specialized responses. Annu Rev Immunol 27:119\u2013145","journal-title":"Annu Rev Immunol"},{"key":"5177_CR4","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/nan.12011","volume":"39","author":"D Boche","year":"2013","unstructured":"Boche D, Perry VH, Nicoll JAR (2013) Review: Activation patterns of microglia and their identification in the human brain. Neuropathol Appl Neurobiol 39:3\u201318","journal-title":"Neuropathol Appl Neurobiol"},{"key":"5177_CR5","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1161\/STROKEAHA.112.659656","volume":"43","author":"X Hu","year":"2012","unstructured":"Hu X, Li P, Guo Y, Wang H, Leak RK, Chen S et al (2012) Microglia\/macrophage polarization dynamics reveal novel mechanism of injury expansion after focal cerebral ischemia. Stroke 43:3063\u20133070","journal-title":"Stroke"},{"key":"5177_CR6","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/nrn3898","volume":"16","author":"MV Sofroniew","year":"2015","unstructured":"Sofroniew MV (2015) Astrocyte barriers to neurotoxic inflammation. Nat Rev Neurosci 16:249\u2013263","journal-title":"Nat Rev Neurosci"},{"key":"5177_CR7","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/nrn.2016.159","volume":"18","author":"LB Haim","year":"2016","unstructured":"Haim LB, Rowitch DH (2016) Functional diversity of astrocytes in neural circuit regulation. Nat Rev Neurosci 18:31\u201341","journal-title":"Nat Rev Neurosci"},{"key":"5177_CR8","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1038\/s41423-021-00757-x","volume":"18","author":"I Galea","year":"2021","unstructured":"Galea I (2021) The blood\u2013brain barrier in systemic infection and inflammation. Cell Mol Immunol 18:2489\u20132501","journal-title":"Cell Mol Immunol"},{"key":"5177_CR9","unstructured":"Dion-Albert L, Cadoret A, Doney E, Kaufmann FN, Dudek KA, Daigle B et al (2020) Vascular and blood-brain barrier-related changes underlie stress responses and resilience in female mice and depression in human tissue. Nat Commun; 13."},{"key":"5177_CR10","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1038\/s41593-017-0010-3","volume":"20","author":"C Menard","year":"2017","unstructured":"Menard C, Pfau ML, Hodes GE, Kana V, Wang VX, Bouchard S et al (2017) Social stress induces neurovascular pathology promoting depression. Nat Neurosci 20:1752\u20131760","journal-title":"Nat Neurosci"},{"key":"5177_CR11","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.bbi.2018.02.003","volume":"69","author":"Y Cheng","year":"2018","unstructured":"Cheng Y, Desse S, Martinez A, Worthen RJ, Jope RS, Beurel E (2018) TNF\u03b1 disrupts blood brain barrier integrity to maintain prolonged depressive-like behavior in mice. Brain Behav Immun 69:556\u2013567","journal-title":"Brain Behav Immun"},{"key":"5177_CR12","doi-asserted-by":"crossref","unstructured":"Kamintsky L, Cairns KA, Veksler R, Bowen C, Beyea SD, Friedman A et al (2020) Blood-brain barrier imaging as a potential biomarker for bipolar disorder progression. Neuroimage Clin; 26.","DOI":"10.1016\/j.nicl.2019.102049"},{"key":"5177_CR13","doi-asserted-by":"crossref","unstructured":"Medina-Rodriguez EM, Beurel E (2022) Blood brain barrier and inflammation in depression. Neurobiol Dis; 175","DOI":"10.1016\/j.nbd.2022.105926"},{"key":"5177_CR14","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/S2215-0366(20)30255-8","volume":"7","author":"JH Meyer","year":"2020","unstructured":"Meyer JH, Cervenka S, Kim M-J, Kreisl WC, Henter ID, Innis RB (2020) Neuroinflammation in psychiatric disorders: PET imaging and promising new targets. Lancet Psychiatry 7:1064\u20131074","journal-title":"Lancet Psychiatry"},{"key":"5177_CR15","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.tips.2006.06.005","volume":"27","author":"V Papadopoulos","year":"2006","unstructured":"Papadopoulos V, Baraldi M, Guilarte TR, Knudsen TB, Lacap\u00e8re J-J, Lindemann P et al (2006) Translocator protein (18kDa): new nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular function. Trends Pharmacol Sci 27:402\u2013409","journal-title":"Trends Pharmacol Sci"},{"key":"5177_CR16","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1042\/BST20150058","volume":"43","author":"E Turkheimer Federico","year":"2015","unstructured":"Turkheimer Federico E, Rizzo G, Bloomfield Peter S, Howes O, Zanotti-Fregonara P, Bertoldo A et al (2015) The methodology of TSPO imaging with positron emission tomography. Biochem Soc Trans 43:586\u2013592","journal-title":"Biochem Soc Trans"},{"key":"5177_CR17","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.biopsych.2020.03.007","volume":"88","author":"S Attwells","year":"2020","unstructured":"Attwells S, Setiawan E, Rusjan PM, Xu C, Hutton C, Rafiei D et al (2020) Translocator protein distribution volume predicts reduction of symptoms during open-label trial of celecoxib in major depressive disorder. Biol Psychiatry 88:649\u2013656","journal-title":"Biol Psychiatry"},{"key":"5177_CR18","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1038\/nrd3295","volume":"9","author":"R Rupprecht","year":"2010","unstructured":"Rupprecht R, Papadopoulos V, Rammes G, Baghai TC, Fan J, Akula N et al (2010) Translocator protein (18 kDa) (TSPO) as a therapeutic target for neurological and psychiatric disorders. Nat Rev Drug Discov 9:971\u2013988","journal-title":"Nat Rev Drug Discov"},{"key":"5177_CR19","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.mce.2006.12.004","volume":"265\u2013266","author":"V Papadopoulos","year":"2007","unstructured":"Papadopoulos V, Liu J, Culty M (2007) Is there a mitochondrial signaling complex facilitating cholesterol import? Mol Cell Endocrinol 265\u2013266:59\u201364","journal-title":"Mol Cell Endocrinol"},{"key":"5177_CR20","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1210\/en.2013-2033","volume":"155","author":"V Papadopoulos","year":"2014","unstructured":"Papadopoulos V (2014) On the role of the translocator protein (18-kDa) TSPO in steroid hormone biosynthesis. Endocrinology 155:15\u201320","journal-title":"Endocrinology"},{"key":"5177_CR21","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.mce.2013.04.014","volume":"379","author":"WL Miller","year":"2013","unstructured":"Miller WL (2013) Steroid hormone synthesis in mitochondria. Mol Cell Endocrinol 379:62\u201373","journal-title":"Mol Cell Endocrinol"},{"key":"5177_CR22","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1210\/en.2013-1556","volume":"155","author":"K Morohaku","year":"2014","unstructured":"Morohaku K, Pelton SH, Daugherty DJ, Butler WR, Deng W, Selvaraj V (2014) Translocator protein\/peripheral benzodiazepine receptor is not required for steroid hormone biosynthesis. Endocrinology 155:89\u201397","journal-title":"Endocrinology"},{"key":"5177_CR23","doi-asserted-by":"crossref","first-page":"5452","DOI":"10.1038\/ncomms6452","volume":"5","author":"RB Banati","year":"2014","unstructured":"Banati RB, Middleton RJ, Chan R, Hatty CR, Kam WW, Quin C et al (2014) Positron emission tomography and functional characterization of a complete PBR\/TSPO knockout. Nat Commun 5:5452","journal-title":"Nat Commun"},{"key":"5177_CR24","doi-asserted-by":"crossref","first-page":"9924","DOI":"10.1021\/bi050150s","volume":"44","author":"E Levin","year":"2005","unstructured":"Levin E, Premkumar A, Veenman L, Kugler W, Leschiner S, Spanier I et al (2005) The peripheral-type benzodiazepine receptor and tumorigenicity: isoquinoline binding protein (IBP) antisense knockdown in the C6 glioma cell line. Biochemistry 44:9924\u20139935","journal-title":"Biochemistry"},{"key":"5177_CR25","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1210\/me.2004-0307","volume":"19","author":"T Hauet","year":"2005","unstructured":"Hauet T, Yao Z-X, Bose HS, Wall CT, Han Z, Li W et al (2005) Peripheral-type benzodiazepine receptor-mediated action of steroidogenic acute regulatory protein on cholesterol entry into Leydig cell mitochondria. Mol Endocrinol 19:540\u2013554","journal-title":"Mol Endocrinol"},{"key":"5177_CR26","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1016\/j.bcp.2004.01.021","volume":"67","author":"D Kletsas","year":"2004","unstructured":"Kletsas D, Li W, Han Z, Papadopoulos V (2004) Peripheral-type benzodiazepine receptor (PBR) and PBR drug ligands in fibroblast and fibrosarcoma cell proliferation: role of ERK, c-Jun and ligand-activated PBR-independent pathways. Biochem Pharmacol 67:1927\u20131932","journal-title":"Biochem Pharmacol"},{"key":"5177_CR27","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.bcp.2006.10.025","volume":"73","author":"W Li","year":"2007","unstructured":"Li W, Hardwick MJ, Rosenthal D, Culty M, Papadopoulos V (2007) Peripheral-type benzodiazepine receptor overexpression and knockdown in human breast cancer cells indicate its prominent role in tumor cell proliferation. Biochem Pharmacol 73:491\u2013503","journal-title":"Biochem Pharmacol"},{"key":"5177_CR28","doi-asserted-by":"crossref","first-page":"4652","DOI":"10.1021\/bi900064t","volume":"48","author":"S Zeno","year":"2009","unstructured":"Zeno S, Zaaroor M, Leschiner S, Veenman L, Gavish M (2009) CoCl(2) induces apoptosis via the 18 kDa translocator protein in U118MG human glioblastoma cells. Biochemistry 48:4652\u20134661","journal-title":"Biochemistry"},{"key":"5177_CR29","doi-asserted-by":"crossref","unstructured":"Gavish M, Veenman L (2018) Regulation of mitochondrial, cellular, and organismal functions by TSPO. In: Apprentices to genius: a tribute to Solomon H. Snyder p103\u201336","DOI":"10.1016\/bs.apha.2017.09.004"},{"key":"5177_CR30","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1042\/BST20150037","volume":"43","author":"J Gatliff","year":"2015","unstructured":"Gatliff J, Campanella M (2015) TSPO is a REDOX regulator of cell mitophagy. Biochem Soc Trans 43:543\u2013552","journal-title":"Biochem Soc Trans"},{"key":"5177_CR31","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.tibs.2015.02.003","volume":"40","author":"BJ Ryan","year":"2015","unstructured":"Ryan BJ, Hoek S, Fon EA, Wade-Martins R (2015) Mitochondrial dysfunction and mitophagy in Parkinson\u2019s: from familial to sporadic disease. Trends Biochem Sci 40:200\u2013210","journal-title":"Trends Biochem Sci"},{"key":"5177_CR32","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2014.581","volume":"6","author":"B Khalil","year":"2015","unstructured":"Khalil B, El Fissi N, Aouane A, Cabirol-Pol MJ, Rival T, Li\u00e9vens JC (2015) PINK1-induced mitophagy promotes neuroprotection in Huntington\u2019s disease. Cell Death Dis 6:e1617","journal-title":"Cell Death Dis"},{"key":"5177_CR33","doi-asserted-by":"crossref","first-page":"2938","DOI":"10.1093\/hmg\/ddv056","volume":"24","author":"X Ye","year":"2015","unstructured":"Ye X, Sun X, Starovoytov V, Cai Q (2015) Parkin-mediated mitophagy in mutant hAPP neurons and Alzheimer\u2019s disease patient brains. Hum Mol Genet 24:2938\u20132951","journal-title":"Hum Mol Genet"},{"key":"5177_CR34","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s10863-014-9584-6","volume":"47","author":"NJ Klinedinst","year":"2014","unstructured":"Klinedinst NJ, Regenold WT (2014) A mitochondrial bioenergetic basis of depression. J Bioenerg Biomembr 47:155\u2013171","journal-title":"J Bioenerg Biomembr"},{"key":"5177_CR35","doi-asserted-by":"crossref","unstructured":"Kuffner K, Triebelhorn J, Meindl K, Benner C, Manook A, Sudria-Lopez D et al (2018) Major depressive disorder is associated with impaired mitochondrial function in skin fibroblasts. Cells 9","DOI":"10.3390\/cells9040884"},{"key":"5177_CR36","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1007\/s13311-015-0385-3","volume":"12","author":"RM Ransohoff","year":"2015","unstructured":"Ransohoff RM, Schafer D, Vincent A, Blach\u00e8re NE, Bar-Or A (2015) Neuroinflammation: ways in which the immune system affects the brain. Neurotherapeutics 12:896\u2013909","journal-title":"Neurotherapeutics"},{"key":"5177_CR37","doi-asserted-by":"crossref","first-page":"5201","DOI":"10.1007\/s10072-024-07648-9","volume":"45","author":"L Qin","year":"2024","unstructured":"Qin L, Xiao L, Zhu H, Du Y, Tang Y, Feng L (2024) Translocator protein (18 kDa) positron emission tomography imaging as a biomarker of neuroinflammation in epilepsy. Neurol Sci 45:5201\u20135211","journal-title":"Neurol Sci"},{"key":"5177_CR38","doi-asserted-by":"crossref","first-page":"S63","DOI":"10.5213\/inj.1938226.113","volume":"23","author":"SH Maeng","year":"2019","unstructured":"Maeng SH, Hong H (2019) Inflammation as the potential basis in depression. Int Neurourol J 23:S63-71","journal-title":"Int Neurourol J"},{"key":"5177_CR39","doi-asserted-by":"crossref","first-page":"10809","DOI":"10.1523\/JNEUROSCI.1487-12.2012","volume":"32","author":"S Lavisse","year":"2012","unstructured":"Lavisse S, Guillermier M, H\u00e9rard A-S, Petit F, Delahaye M, Van Camp N et al (2012) Reactive astrocytes overexpress TSPO and are detected by TSPO positron emission tomography imaging. J Neurosci 32:10809\u201310818","journal-title":"J Neurosci"},{"key":"5177_CR40","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1038\/s41380-020-0745-1","volume":"26","author":"T Notter","year":"2021","unstructured":"Notter T, Schalbetter SM, Clifton NE, Mattei D, Richetto J, Thomas K et al (2021) Neuronal activity increases translocator protein (TSPO) levels. Mol Psychiatry 26:2025\u20132037","journal-title":"Mol Psychiatry"},{"key":"5177_CR41","doi-asserted-by":"crossref","first-page":"3440","DOI":"10.1093\/brain\/awz287","volume":"142","author":"E Nutma","year":"2019","unstructured":"Nutma E, Stephenson JA, Gorter RP, de Bruin J, Boucherie DM, Donat CK et al (2019) A quantitative neuropathological assessment of translocator protein expression in multiple sclerosis. Brain 142:3440\u20133455","journal-title":"Brain"},{"key":"5177_CR42","doi-asserted-by":"crossref","first-page":"2918","DOI":"10.1038\/s41380-022-01561-3","volume":"27","author":"R Rupprecht","year":"2022","unstructured":"Rupprecht R, Wetzel CH, Dorostkar M, Herms J, Albert NL, Schwarzbach J et al (2022) Translocator protein (18kDa) TSPO: a new diagnostic or therapeutic target for stress-related disorders? Mol Psychiatry 27:2918\u20132926","journal-title":"Mol Psychiatry"},{"key":"5177_CR43","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1007\/s00259-008-0908-9","volume":"35","author":"F Chauveau","year":"2008","unstructured":"Chauveau F, Boutin H, Van Camp N, Doll\u00e9 F, Tavitian B (2008) Nuclear imaging of neuroinflammation: a comprehensive review of [11C]PK11195 challengers. Eur J Nucl Med Mol Imaging 35:2304\u20132319","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"5177_CR44","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.2174\/092986709788803150","volume":"16","author":"F Doll\u00e9","year":"2009","unstructured":"Doll\u00e9 F, Luus C, Reynolds A, Kassiou M (2009) Radiolabelled molecules for imaging the translocator protein (18 kDa) using positron emission tomography. Curr Med Chem 16:2899\u20132923","journal-title":"Curr Med Chem"},{"key":"5177_CR45","doi-asserted-by":"crossref","first-page":"3429","DOI":"10.1021\/jm4001874","volume":"56","author":"D Tang","year":"2013","unstructured":"Tang D, McKinley ET, Hight MR, Uddin MI, Harp JM, Fu A et al (2013) Synthesis and structure-activity relationships of 5,6,7-substituted pyrazolopyrimidines: discovery of a novel TSPO PET ligand for cancer imaging. J Med Chem 56:3429\u20133433","journal-title":"J Med Chem"},{"key":"5177_CR46","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1021\/jm8011678","volume":"52","author":"AM Scarf","year":"2009","unstructured":"Scarf AM, Ittner LM, Kassiou M (2009) The translocator protein (18 kDa): central nervous system disease and drug design. J Med Chem 52:581\u2013592","journal-title":"J Med Chem"},{"key":"5177_CR47","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.neulet.2006.09.093","volume":"411","author":"M Imaizumi","year":"2007","unstructured":"Imaizumi M, Kim HJ, Zoghbi SS, Briard E, Hong J, Musachio JL et al (2007) PET imaging with [11C]PBR28 can localize and quantify upregulated peripheral benzodiazepine receptors associated with cerebral ischemia in rat. Neurosci Lett 411:200\u2013205","journal-title":"Neurosci Lett"},{"key":"5177_CR48","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S0969-8051(03)00016-7","volume":"30","author":"MR Zhang","year":"2003","unstructured":"Zhang MR, Kida T, Noguchi J, Furutsuka K, Maeda J, Suhara T et al (2003) [(11)C]DAA1106: radiosynthesis and in vivo binding to peripheral benzodiazepine receptors in mouse brain. Nucl Med Biol 30:513\u2013519","journal-title":"Nucl Med Biol"},{"key":"5177_CR49","doi-asserted-by":"crossref","first-page":"320","DOI":"10.2967\/jnumed.116.178996","volume":"58","author":"M Ikawa","year":"2017","unstructured":"Ikawa M, Lohith TG, Shrestha S, Telu S, Zoghbi SS, Castellano S et al (2017) 11C-ER176, a radioligand for 18-kDa translocator protein, has adequate sensitivity to robustly image all three affinity genotypes in human brain. J Nucl Med 58:320\u2013325","journal-title":"J Nucl Med"},{"key":"5177_CR50","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.2967\/jnumed.115.169078","volume":"57","author":"Z Fan","year":"2016","unstructured":"Fan Z, Calsolaro V, Atkinson RA, Femminella GD, Waldman A, Buckley C et al (2016) Flutriciclamide (18F-GE180) PET: first-in-human PET study of novel third-generation in vivo marker of human translocator protein. J Nucl Med 57:1753\u20131759","journal-title":"J Nucl Med"},{"key":"5177_CR51","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S2215-0366(18)30048-8","volume":"5","author":"E Setiawan","year":"2018","unstructured":"Setiawan E, Attwells S, Wilson AA, Mizrahi R, Rusjan PM, Miler L et al (2018) Association of translocator protein total distribution volume with duration of untreated major depressive disorder: a cross-sectional study. Lancet Psychiatry 5:339\u2013347","journal-title":"Lancet Psychiatry"},{"key":"5177_CR52","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.2174\/092986706777584979","volume":"13","author":"ML James","year":"2006","unstructured":"James ML, Selleri S, Kassiou M (2006) Development of ligands for the peripheral benzodiazepine receptor. Curr Med Chem 13:1991\u20132001","journal-title":"Curr Med Chem"},{"key":"5177_CR53","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1038\/sj.jcbfm.9600493","volume":"27","author":"RB Innis","year":"2007","unstructured":"Innis RB, Cunningham VJ, Delforge J, Fujita M, Gjedde A, Gunn RN et al (2007) Consensus nomenclature for in vivo imaging of reversibly binding radioligands. J Cereb Blood Flow Metab 27:1533\u20131539","journal-title":"J Cereb Blood Flow Metab"},{"key":"5177_CR54","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0030442","volume":"3","author":"CD Mathers","year":"2006","unstructured":"Mathers CD, Loncar D (2006) Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 3:e442","journal-title":"PLoS Med"},{"key":"5177_CR55","doi-asserted-by":"crossref","unstructured":"Afridi R, Suk K (2021) Neuroinflammatory basis of depression: learning from experimental models. Front Cell Neurosci 15","DOI":"10.3389\/fncel.2021.691067"},{"key":"5177_CR56","doi-asserted-by":"crossref","unstructured":"Richards EM, Zanotti-Fregonara P, Fujita M, Newman L, Farmer C, Ballard ED et al (2018) PET radioligand binding to translocator protein (TSPO) is increased in unmedicated depressed subjects. EJNMMI Res 8","DOI":"10.1186\/s13550-018-0401-9"},{"key":"5177_CR57","doi-asserted-by":"crossref","unstructured":"Setiawan E, Wilson AA, Mizrahi R, Rusjan PM, Miler L, Rajkowska G et al\u00a0(2015) Role of translocator protein density, a marker of neuroinflammation, in the brain during major depressive episodes. JAMA Psychiatry 72","DOI":"10.1001\/jamapsychiatry.2014.2427"},{"key":"5177_CR58","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pnpbp.2017.12.011","volume":"83","author":"H Li","year":"2018","unstructured":"Li H, Sagar AP, K\u00e9ri S (2018) Translocator protein (18 kDa TSPO) binding, a marker of microglia, is reduced in major depression during cognitive-behavioral therapy. Prog Neuro-Psychopharmacol Biol Psychiatry 83:1\u20137","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"5177_CR59","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.jad.2018.08.021","volume":"241","author":"H Li","year":"2018","unstructured":"Li H, Sagar AP, K\u00e9ri S (2018) Microglial markers in the frontal cortex are related to cognitive dysfunctions in major depressive disorder. J Affect Disord 241:305\u2013310","journal-title":"J Affect Disord"},{"key":"5177_CR60","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.biopsych.2017.08.005","volume":"83","author":"SE Holmes","year":"2018","unstructured":"Holmes SE, Hinz R, Conen S, Gregory CJ, Matthews JC, Anton-Rodriguez JM et al (2018) Elevated translocator protein in anterior cingulate in major depression and a role for inflammation in suicidal thinking: a positron emission tomography study. Biol Psychiatry 83:61\u201369","journal-title":"Biol Psychiatry"},{"key":"5177_CR61","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1192\/bjp.bp.116.190165","volume":"209","author":"L Su","year":"2016","unstructured":"Su L, Faluyi YO, Hong YT, Fryer TD, Mak E, Gabel S et al (2016) Neuroinflammatory and morphological changes in late-life depression: the NIMROD study. Br J Psychiatry 209:525\u2013526","journal-title":"Br J Psychiatry"},{"key":"5177_CR62","doi-asserted-by":"crossref","unstructured":"Joo Y-H, Lee M-W, Son Y-D, Chang K-A, Yaqub M, Kim H-K et al\u00a0(2021) In vivo cerebral translocator protein (TSPO) binding and its relationship with blood adiponectin levels in treatment-na\u00efve young adults with major depression: a [11C]PK11195 PET study. Bio 10","DOI":"10.3390\/biomedicines10010034"},{"key":"5177_CR63","first-page":"716","volume":"6","author":"JJ Schubert","year":"2021","unstructured":"Schubert JJ, Veronese M, Fryer TD, Manavaki R, Kitzbichler MG, Nettis MA et al (2021) A modest increase in 11C-PK11195-positron emission tomography TSPO binding in depression is not associated with serum C-reactive protein or body mass index. Biol Psychiatry Cogn Neurosci Neuroimaging 6:716\u2013724","journal-title":"Biol Psychiatry Cogn Neurosci Neuroimaging"},{"key":"5177_CR64","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.bbi.2019.06.015","volume":"81","author":"D Enache","year":"2019","unstructured":"Enache D, Pariante CM, Mondelli V (2019) Markers of central inflammation in major depressive disorder: a systematic review and meta-analysis of studies examining cerebrospinal fluid, positron emission tomography and post-mortem brain tissue. Brain Behav Immun 81:24\u201340","journal-title":"Brain Behav Immun"},{"key":"5177_CR65","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.bbi.2013.06.010","volume":"33","author":"J Hannestad","year":"2013","unstructured":"Hannestad J, DellaGioia N, Gallezot J-D, Lim K, Nabulsi N, Esterlis I et al (2013) The neuroinflammation marker translocator protein is not elevated in individuals with mild-to-moderate depression: a [11C]PBR28 PET study. Brain Behav Immun 33:131\u2013138","journal-title":"Brain Behav Immun"},{"key":"5177_CR66","doi-asserted-by":"crossref","unstructured":"Eggerstorfer B, Kim J-H, Cumming P, Lanzenberger R, Gryglewski G (2022) Meta-analysis of molecular imaging of translocator protein in major depression. Front Mol Neurosci 15","DOI":"10.3389\/fnmol.2022.981442"},{"key":"5177_CR67","doi-asserted-by":"crossref","unstructured":"G\u0119dek A, Szular Z, Antosik AZ, Mierzejewski P, Dominiak M (2023) Celecoxib for mood disorders: a systematic review and meta-analysis of randomized controlled trials. J Clin Med 12","DOI":"10.3390\/jcm12103497"},{"key":"5177_CR68","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1177\/0004867420965697","volume":"55","author":"R Zazula","year":"2020","unstructured":"Zazula R, Husain MI, Mohebbi M, Walker AJ, Chaudhry IB, Khoso AB et al (2020) Minocycline as adjunctive treatment for major depressive disorder: pooled data from two randomized controlled trials. Aust N Z J Psychiatry 55:784\u2013798","journal-title":"Aust N Z J Psychiatry"},{"key":"5177_CR69","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2019.04.034","volume":"145","author":"C Mattei","year":"2019","unstructured":"Mattei C, Taly A, Soualah Z, Saulais O, Henrion D, Gu\u00e9rineau NC et al (2019) Involvement of the GABA(A) receptor \u03b1 subunit in the mode of action of etifoxine. Pharmacol Res 145:104250","journal-title":"Pharmacol Res"},{"key":"5177_CR70","doi-asserted-by":"crossref","unstructured":"Riebel M, Brunner L-M, Nothdurfter C, Wein S, Schwarzbach J, Liere P et al\u00a0(2024) Neurosteroids and translocator protein 18\u00a0kDa (TSPO) ligands as novel treatment options in depression. Eur Arch Psychiatry Clin Neurosci","DOI":"10.1007\/s00406-024-01843-7"},{"key":"5177_CR71","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.ebiom.2018.03.019","volume":"30","author":"AK Bhandage","year":"2018","unstructured":"Bhandage AK, Jin Z, Korol SV, Shen Q, Pei Y, Deng Q et al (2018) GABA regulates release of inflammatory cytokines from peripheral blood mononuclear cells and CD4+ T cells and is immunosuppressive in type 1 diabetes. EBioMedicine 30:283\u2013294","journal-title":"EBioMedicine"},{"key":"5177_CR72","doi-asserted-by":"crossref","unstructured":"Kim JK, Kim YS, Lee H-M, Jin HS, Neupane C, Kim S et al (2018) GABAergic signaling linked to autophagy enhances host protection against intracellular bacterial infections. Nat Commun 9","DOI":"10.1038\/s41467-018-06487-5"},{"key":"5177_CR73","doi-asserted-by":"crossref","unstructured":"Tovar-Gudi\u00f1o E, Guevara-Salazar JA, Bahena-Herrera JR, Trujillo-Ferrara JG, Mart\u00ednez-Campos Z, Razo-Hern\u00e1ndez RS et al\u00a0(2018) Novel-substituted heterocyclic GABA analogues. Enzymatic activity against the GABA-AT enzyme from Pseudomonas fluorescens and in silico molecular modeling. Molecules 23","DOI":"10.3390\/molecules23051128"},{"key":"5177_CR74","doi-asserted-by":"crossref","unstructured":"Bannister E (2019) There is increasing evidence to suggest that brain inflammation could play a key role in the aetiology of psychiatric illness. Could inflammation be a cause of the premenstrual syndromes PMS and PMDD? Post Reprod Health 25:157\u201361","DOI":"10.1177\/2053369119875386"},{"key":"5177_CR75","doi-asserted-by":"crossref","unstructured":"B\u00e4ckstr\u00f6m T, Doverskog M, Blackburn TP, Scharschmidt BF, Felipo V (2024) Allopregnanolone and its antagonist modulate neuroinflammation and neurological impairment. Neurosci Biobehav Rev 161","DOI":"10.1016\/j.neubiorev.2024.105668"},{"key":"5177_CR76","doi-asserted-by":"crossref","unstructured":"Coirini H, Rey M (2015) Synthetic neurosteroids on brain protection. Neural Regen Res 10","DOI":"10.4103\/1673-5374.150640"},{"key":"5177_CR77","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1586\/17446651.1.4.517","volume":"1","author":"D Eser","year":"2006","unstructured":"Eser D, Romeo E, Baghai TC, Sch\u00fcle C, Zwanzger P, Rupprecht R (2006) Neuroactive steroids as modulators of depression and anxiety. Expert Rev Endocrinol Metab 1:517\u2013526","journal-title":"Expert Rev Endocrinol Metab"},{"key":"5177_CR78","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.neubiorev.2012.10.005","volume":"37","author":"CF Zorumski","year":"2013","unstructured":"Zorumski CF, Paul SM, Izumi Y, Covey DF, Mennerick S (2013) Neurosteroids, stress and depression: potential therapeutic opportunities. Neurosci Biobehav Rev 37:109\u2013122","journal-title":"Neurosci Biobehav Rev"},{"key":"5177_CR79","doi-asserted-by":"crossref","unstructured":"Mel\u00f3n L, Hammond R, Lewis M, Maguire J (2018) A novel, synthetic, neuroactive steroid is effective at decreasing depression-like behaviors and improving maternal care in preclinical models of postpartum depression. Front Endocrinol (Lausanne) 9","DOI":"10.3389\/fendo.2018.00703"},{"key":"5177_CR80","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.jad.2023.08.027","volume":"340","author":"S Meshkat","year":"2023","unstructured":"Meshkat S, Teopiz KM, Di Vincenzo JD, Bailey JB, Rosenblat JD, Ho RC et al (2023) Clinical efficacy and safety of Zuranolone (SAGE-217) in individuals with major depressive disorder. J Affect Disord 340:893\u2013898","journal-title":"J Affect Disord"},{"key":"5177_CR81","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1007\/s12035-020-02136-5","volume":"58","author":"AM Barron","year":"2020","unstructured":"Barron AM, Higuchi M, Hattori S, Kito S, Suhara T, Ji B (2020) Regulation of anxiety and depression by mitochondrial translocator protein-mediated steroidogenesis: the role of neurons. Mol Neurobiol 58:550\u2013563","journal-title":"Mol Neurobiol"},{"key":"5177_CR82","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1007\/s11064-020-03036-9","volume":"45","author":"P Ren","year":"2020","unstructured":"Ren P, Ma L, Wang J-Y, Guo H, Sun L, Gao M-L et al (2020) Anxiolytic and anti-depressive like effects of translocator protein (18 kDa) ligand YL-IPA08 in a rat model of postpartum depression. Neurochem Res 45:1746\u20131757","journal-title":"Neurochem Res"},{"key":"5177_CR83","doi-asserted-by":"crossref","unstructured":"Nozaki K, Ito H, Ohgidani M, Yamawaki Y, Sahin EH, Kitajima T et al\u00a0(2020) Antidepressant effect of the translocator protein antagonist ONO-2952 on mouse behaviors under chronic social defeat stress. Neuropharmacology 162","DOI":"10.1016\/j.neuropharm.2019.107835"},{"key":"5177_CR84","doi-asserted-by":"crossref","first-page":"456","DOI":"10.5334\/tohm.376","volume":"7","author":"SL Dean","year":"2017","unstructured":"Dean SL, Singer HS (2017) Treatment of Sydenham\u2019s chorea: a review of the current evidence. Tremor Other Hyperkinet Mov (N Y) 7:456","journal-title":"Tremor Other Hyperkinet Mov (N Y)"},{"key":"5177_CR85","doi-asserted-by":"crossref","unstructured":"Meyer J (2021) Inflammation, obsessive-compulsive disorder, and related disorders. In: The neurobiology and treatment of OCD: accelerating progress. Chap 210:p31\u201353","DOI":"10.1007\/7854_2020_210"},{"key":"5177_CR86","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.2147\/NDT.S62785","volume":"11","author":"P Alonso","year":"2015","unstructured":"Alonso P, L\u00f3pez-Sol\u00e0 C, Real E, Segal\u00e0s C, Mench\u00f3n JM (2015) Animal models of obsessive-compulsive disorder: utility and limitations. Neuropsychiatr Dis Treat 11:1939\u20131955","journal-title":"Neuropsychiatr Dis Treat"},{"key":"5177_CR87","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1517\/17460441.2016.1103225","volume":"11","author":"M Grados","year":"2015","unstructured":"Grados M, Prazak M, Saif A, Halls A (2015) A review of animal models of obsessive-compulsive disorder: a focus on developmental, immune, endocrine and behavioral models. Expert Opin Drug Discov 11:27\u201343","journal-title":"Expert Opin Drug Discov"},{"key":"5177_CR88","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1093\/ibd\/izy400","volume":"25","author":"D Leone","year":"2019","unstructured":"Leone D, Gilardi D, Corr\u00f2 BE, Menichetti J, Vegni E, Correale C et al (2019) Psychological characteristics of inflammatory bowel disease patients: a comparison between active and nonactive patients. Inflamm Bowel Dis 25:1399\u20131407","journal-title":"Inflamm Bowel Dis"},{"key":"5177_CR89","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1017\/S1461145705005055","volume":"8","author":"KH Adams","year":"2005","unstructured":"Adams KH, Hansen ES, Pinborg LH, Hasselbalch SG, Svarer C, Holm S et al (2005) Patients with obsessive\u2013compulsive disorder have increased 5-HT2A receptor binding in the caudate nuclei. Int J Neuropsychopharmacol 8:391\u2013401","journal-title":"Int J Neuropsychopharmacol"},{"key":"5177_CR90","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1017\/S1461145710001604","volume":"14","author":"S Hesse","year":"2011","unstructured":"Hesse S, Stengler K, Regenthal R, Patt M, Becker GA, Franke A et al (2011) The serotonin transporter availability in untreated early-onset and late-onset patients with obsessive-compulsive disorder. Int J Neuropsychopharmacol 14:606\u2013617","journal-title":"Int J Neuropsychopharmacol"},{"key":"5177_CR91","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jad.2016.02.021","volume":"196","author":"C Pittenger","year":"2016","unstructured":"Pittenger C, Adams TG Jr, Gallezot JD, Crowley MJ, Nabulsi N, James R et al (2016) OCD is associated with an altered association between sensorimotor gating and cortical and subcortical 5-HT1b receptor binding. J Affect Disord 196:87\u201396","journal-title":"J Affect Disord"},{"key":"5177_CR92","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1017\/S1461145714000716","volume":"17","author":"F Akkus","year":"2014","unstructured":"Akkus F, Terbeck S, Ametamey SM, Rufer M, Treyer V, Burger C et al (2014) Metabotropic glutamate receptor 5 binding in patients with obsessive-compulsive disorder. Int J Neuropsychopharmacol 17:1915\u20131922","journal-title":"Int J Neuropsychopharmacol"},{"key":"5177_CR93","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1038\/sj.npp.1301528","volume":"33","author":"DF Wong","year":"2008","unstructured":"Wong DF, Brasi\u0107 JR, Singer HS, Schretlen DJ, Kuwabara H, Zhou Y et al (2008) Mechanisms of dopaminergic and serotonergic neurotransmission in Tourette syndrome: clues from an in vivo neurochemistry study with PET. Neuropsychopharmacology 33:1239\u20131251","journal-title":"Neuropsychopharmacology"},{"key":"5177_CR94","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.neuroimage.2009.07.069","volume":"49","author":"R Matsumoto","year":"2010","unstructured":"Matsumoto R, Ichise M, Ito H, Ando T, Takahashi H, Ikoma Y et al (2010) Reduced serotonin transporter binding in the insular cortex in patients with obsessive-compulsive disorder: a [11C]DASB PET study. Neuroimage 49:121\u2013126","journal-title":"Neuroimage"},{"key":"5177_CR95","doi-asserted-by":"crossref","first-page":"65704","DOI":"10.1155\/2007\/65704","volume":"2007","author":"N Konuk","year":"2007","unstructured":"Konuk N, Tekin IO, Ozturk U, Atik L, Atasoy N, Bektas S et al (2007) Plasma levels of tumor necrosis factor-alpha and interleukin-6 in obsessive compulsive disorder. Mediators Inflamm 2007:65704","journal-title":"Mediators Inflamm"},{"key":"5177_CR96","doi-asserted-by":"crossref","first-page":"4751","DOI":"10.1007\/s12035-018-1409-x","volume":"56","author":"TD Cosco","year":"2019","unstructured":"Cosco TD, Pillinger T, Emam H, Solmi M, Budhdeo S, Matthew Prina A et al (2019) Immune aberrations in obsessive-compulsive disorder: a systematic review and meta-analysis. Mol Neurobiol 56:4751\u20134759","journal-title":"Mol Neurobiol"},{"key":"5177_CR97","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1177\/0883073814543303","volume":"30","author":"A Kumar","year":"2015","unstructured":"Kumar A, Williams MT, Chugani HT (2015) Evaluation of basal ganglia and thalamic inflammation in children with pediatric autoimmune neuropsychiatric disorders associated with streptococcal infection and tourette syndrome: a positron emission tomographic (PET) study using 11C-[R]-PK11195. J Child Neurol 30:749\u2013756","journal-title":"J Child Neurol"},{"key":"5177_CR98","doi-asserted-by":"crossref","unstructured":"Attwells S, Setiawan E, Wilson AA, Rusjan PM, Mizrahi R, Miler L et al (2017) Inflammation in the neurocircuitry of obsessive-compulsive disorder. JAMA Psy 74","DOI":"10.1001\/jamapsychiatry.2017.1567"},{"key":"5177_CR99","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1097\/FBP.0000000000000468","volume":"30","author":"D Garabadu","year":"2019","unstructured":"Garabadu D, Kumar V (2019) Celecoxib potentiates the antianxiety and anticompulsive-like activity of fluoxetine against chronic unpredictable mild stress in experimental animals. Behav Pharmacol 30:251\u2013259","journal-title":"Behav Pharmacol"},{"key":"5177_CR100","doi-asserted-by":"crossref","unstructured":"Panizzutti B, Skvarc D, Lin S, Croce S, Meehan A, Bortolasci CC et al\u00a0(2023) Minocycline as treatment for psychiatric and neurological conditions: a systematic review and meta-analysis. Int J Mol Sci 24","DOI":"10.3390\/ijms24065250"},{"key":"5177_CR101","doi-asserted-by":"crossref","first-page":"e766","DOI":"10.4088\/JCP.16m11101","volume":"78","author":"DLC Costa","year":"2017","unstructured":"Costa DLC, Diniz JB, Requena G, Joaquim MA, Pittenger C, Bloch MH et al (2017) Randomized, double-blind, placebo-controlled trial of N-acetylcysteine augmentation for treatment-resistant obsessive-compulsive disorder. J Clin Psychiatry 78:e766\u2013e773","journal-title":"J Clin Psychiatry"},{"key":"5177_CR102","doi-asserted-by":"crossref","first-page":"1753940","DOI":"10.1080\/20008198.2020.1753940","volume":"11","author":"R von der Warth","year":"2020","unstructured":"von der Warth R, Dams J, Grochtdreis T, K\u00f6nig HH (2020) Economic evaluations and cost analyses in posttraumatic stress disorder: a systematic review. Eur J Psychotraumatol 11:1753940","journal-title":"Eur J Psychotraumatol"},{"key":"5177_CR103","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jad.2006.09.018","volume":"101","author":"M Bernal","year":"2007","unstructured":"Bernal M, Haro JM, Bernert S, Brugha T, de Graaf R, Bruffaerts R et al (2007) Risk factors for suicidality in Europe: results from the ESEMED study. J Affect Disord 101:27\u201334","journal-title":"J Affect Disord"},{"key":"5177_CR104","doi-asserted-by":"crossref","unstructured":"Sun Y, Qu Y, Zhu J (2021) The relationship between inflammation and post-traumatic stress disorder. Front Psychiatry 12","DOI":"10.3389\/fpsyt.2021.707543"},{"key":"5177_CR105","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.jad.2023.04.080","volume":"333","author":"C Zuo","year":"2023","unstructured":"Zuo C, Zhuang Z, Yang P, Zhang H, Li X, Huang T et al (2023) Dissecting the causal association between inflammation and post-traumatic stress disorder: a bidirectional Mendelian randomization study. J Affect Disord 333:436\u2013445","journal-title":"J Affect Disord"},{"key":"5177_CR106","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/S2215-0366(15)00309-0","volume":"2","author":"IC Passos","year":"2015","unstructured":"Passos IC, Vasconcelos-Moreno MP, Costa LG, Kunz M, Brietzke E, Quevedo J et al (2015) Inflammatory markers in post-traumatic stress disorder: a systematic review, meta-analysis, and meta-regression. Lancet Psychiatry 2:1002\u20131012","journal-title":"Lancet Psychiatry"},{"key":"5177_CR107","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.bbi.2019.05.042","volume":"80","author":"KL Smith","year":"2019","unstructured":"Smith KL, Kassem MS, Clarke DJ, Kuligowski MP, Bedoya-P\u00e9rez MA, Todd SM et al (2019) Microglial cell hyper-ramification and neuronal dendritic spine loss in the hippocampus and medial prefrontal cortex in a mouse model of PTSD. Brain Behav Immun 80:889\u2013899","journal-title":"Brain Behav Immun"},{"key":"5177_CR108","doi-asserted-by":"crossref","DOI":"10.3389\/fncir.2021.660199","volume":"15","author":"N Chaaya","year":"2021","unstructured":"Chaaya N, Wang J, Jacques A, Beecher K, Chaaya M, Battle AR et al (2021) Contextual fear memory maintenance changes expression of pMAPK, BDNF and IBA-1 in the pre-limbic cortex in a layer-specific manner. Front Neural Circuits 15:660199","journal-title":"Front Neural Circuits"},{"key":"5177_CR109","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jpsychires.2016.02.003","volume":"76","author":"CY Kao","year":"2016","unstructured":"Kao CY, He Z, Zannas AS, Hahn O, K\u00fchne C, Reichel JM et al (2016) Fluoxetine treatment prevents the inflammatory response in a mouse model of posttraumatic stress disorder. J Psychiatr Res 76:74\u201383","journal-title":"J Psychiatr Res"},{"key":"5177_CR110","doi-asserted-by":"crossref","unstructured":"Bhatt S, Hillmer AT, Girgenti MJ, Rusowicz A, Kapinos M, Nabulsi N et al\u00a0(2020) PTSD is associated with neuroimmune suppression: evidence from PET imaging and postmortem transcriptomic studies. Nat Commun 11","DOI":"10.1038\/s41467-020-15930-5"},{"key":"5177_CR111","doi-asserted-by":"crossref","unstructured":"Bonomi R, Hillmer AT, Woodcock E, Bhatt S, Rusowicz A, Angarita GA et al (2024) Microglia-mediated neuroimmune suppression in PTSD is associated with anhedonia. Proc Natl Acad Sci U S A 121:e2406005121","DOI":"10.1073\/pnas.2406005121"},{"key":"5177_CR112","doi-asserted-by":"crossref","unstructured":"Deri Y, Clouston SAP, DeLorenzo C, Gardus JD, Bartlett EA, Santiago-Michels S et al\u00a0(2021) Neuroinflammation in World Trade Center responders at midlife: a pilot study using [18F]-FEPPA PET imaging. Brain Behav Immun Health 16","DOI":"10.1016\/j.bbih.2021.100287"},{"key":"5177_CR113","doi-asserted-by":"crossref","unstructured":"Seo S, Jung YH, Lee D, Lee WJ, Jang JH, Lee JY et al (2021) Abnormal neuroinflammation in fibromyalgia and CRPS using [11C]-(R)-PK11195 PET. PLoS ONE 16:e0246152","DOI":"10.1371\/journal.pone.0246152"},{"key":"5177_CR114","doi-asserted-by":"crossref","unstructured":"Watling SE, Gill T, Gaudette EV, Richardson JD, McCluskey T, Tong J et al\u00a0(2023) Investigating TSPO levels in occupation-related posttraumatic stress disorder. Sci Rep 13","DOI":"10.1038\/s41598-023-31327-y"},{"key":"5177_CR115","doi-asserted-by":"crossref","first-page":"357","DOI":"10.4196\/kjpp.2016.20.4.357","volume":"20","author":"B Lee","year":"2016","unstructured":"Lee B, Sur B, Yeom M, Shim I, Lee H, Hahm DH (2016) Effects of systemic administration of ibuprofen on stress response in a rat model of post-traumatic stress disorder. Korean J Physiol Pharmacol 20:357\u2013366","journal-title":"Korean J Physiol Pharmacol"},{"key":"5177_CR116","doi-asserted-by":"crossref","first-page":"263","DOI":"10.4103\/tcmj.tcmj_243_20","volume":"33","author":"PS Patankar","year":"2021","unstructured":"Patankar PS, Joshi S, Mane A, Manjesh PS, Kokate D (2021) Anxiolytic effect of minocycline in posttraumatic stress disorder model of Syrian hamsters. Tzu Chi Med J 33:263\u2013269","journal-title":"Tzu Chi Med J"},{"key":"5177_CR117","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.pnpbp.2013.04.010","volume":"45","author":"ZK Qiu","year":"2013","unstructured":"Qiu ZK, Zhang LM, Zhao N, Chen HX, Zhang YZ, Liu YQ et al (2013) Repeated administration of AC-5216, a ligand for the 18 kDa translocator protein, improves behavioral deficits in a mouse model of post-traumatic stress disorder. Prog Neuropsychopharmacol Biol Psychiatry 45:40\u201346","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"5177_CR118","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2019.112320","volume":"379","author":"C Shang","year":"2020","unstructured":"Shang C, Guo Y, Yao JQ, Fang XX, Sun LJ, Jiang XY et al (2020) Rapid anti-PTSD-like activity of the TSPO agonist YL-IPA08: emphasis on brain GABA, neurosteroids and HPA axis function. Behav Brain Res 379:112320","journal-title":"Behav Brain Res"},{"key":"5177_CR119","doi-asserted-by":"crossref","first-page":"3226","DOI":"10.1111\/bph.13843","volume":"174","author":"A Locci","year":"2017","unstructured":"Locci A, Pinna G (2017) Neurosteroid biosynthesis down-regulation and changes in GABA(A) receptor subunit composition: a biomarker axis in stress-induced cognitive and emotional impairment. Br J Pharmacol 174:3226\u20133241","journal-title":"Br J Pharmacol"},{"key":"5177_CR120","doi-asserted-by":"crossref","unstructured":"Qiu Z-K, Liu X, Chen Y, Wu R-J, Guan S-F, Pan Y-y et al\u00a0(2020) Translocator protein 18\u00a0kDa: a potential therapeutic biomarker for post traumatic stress disorder. Metab Brain Dis 35:695\u2013707","DOI":"10.1007\/s11011-020-00548-9"},{"key":"5177_CR121","doi-asserted-by":"crossref","unstructured":"Lv H, Guo M, Guo C, He K (2024) The interrelationships between cytokines and schizophrenia: a systematic review. Int J Mol Sci 25","DOI":"10.37766\/inplasy2024.7.0128"},{"key":"5177_CR122","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1001\/jamapsychiatry.2022.0407","volume":"79","author":"JA Williams","year":"2022","unstructured":"Williams JA, Burgess S, Suckling J, Lalousis PA, Batool F, Griffiths SL et al (2022) Inflammation and brain structure in schizophrenia and other neuropsychiatric disorders: a Mendelian randomization study. JAMA Psychiat 79:498\u2013507","journal-title":"JAMA Psychiat"},{"key":"5177_CR123","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/mp.2016.248","volume":"23","author":"T Notter","year":"2018","unstructured":"Notter T, Coughlin JM, Gschwind T, Weber-Stadlbauer U, Wang Y, Kassiou M et al (2018) Translational evaluation of translocator protein as a marker of neuroinflammation in schizophrenia. Mol Psychiatry 23:323\u2013334","journal-title":"Mol Psychiatry"},{"key":"5177_CR124","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1093\/schbul\/sbu157","volume":"41","author":"M Kenk","year":"2015","unstructured":"Kenk M, Selvanathan T, Rao N, Suridjan I, Rusjan P, Remington G et al (2015) Imaging neuroinflammation in gray and white matter in schizophrenia: an in-vivo PET study with [18F]-FEPPA. Schizophr Bull 41:85\u201393","journal-title":"Schizophr Bull"},{"key":"5177_CR125","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1038\/mp.2016.247","volume":"22","author":"K Collste","year":"2017","unstructured":"Collste K, Plav\u00e9n-Sigray P, Fatouros-Bergman H, Victorsson P, Schain M, Forsberg A et al (2017) Lower levels of the glial cell marker TSPO in drug-naive first-episode psychosis patients as measured using PET and [(11)C]PBR28. Mol Psychiatry 22:850\u2013856","journal-title":"Mol Psychiatry"},{"key":"5177_CR126","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/s41398-020-0776-z","volume":"10","author":"H Laurikainen","year":"2020","unstructured":"Laurikainen H, Vuorela A, Toivonen A, Reinert-Hartwall L, Trontti K, Lindgren M et al (2020) Elevated serum chemokine CCL22 levels in first-episode psychosis: associations with symptoms, peripheral immune state and in vivo brain glial cell function. Transl Psychiatry 10:94","journal-title":"Transl Psychiatry"},{"key":"5177_CR127","doi-asserted-by":"crossref","unstructured":"De Picker L, Ottoy J, Verhaeghe J, Deleye S, wyffels L, Fransen E et al\u00a0(2019) State-associated changes in longitudinal [18F]-PBR111 TSPO PET imaging of psychosis patients: evidence for the accelerated ageing hypothesis? Brain Behav Immun 77:46\u201354","DOI":"10.1016\/j.bbi.2018.11.318"},{"key":"5177_CR128","doi-asserted-by":"crossref","unstructured":"Ottoy J, De Picker L, Verhaeghe J, Deleye S, wyffels L, Kosten L et al\u00a0(2018) 18F-PBR111 PET imaging in healthy controls and schizophrenia: test\u2013retest reproducibility and quantification of neuroinflammation. J Nucl Med 59:1267\u201374","DOI":"10.2967\/jnumed.117.203315"},{"key":"5177_CR129","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1176\/appi.ajp.2015.14101358","volume":"173","author":"PS Bloomfield","year":"2016","unstructured":"Bloomfield PS, Selvaraj S, Veronese M, Rizzo G, Bertoldo A, Owen DR et al (2016) Microglial activity in people at ultra high risk of psychosis and in schizophrenia: an [11C]PBR28 PET brain imaging study. Am J Psychiatry 173:44\u201352","journal-title":"Am J Psychiatry"},{"key":"5177_CR130","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1176\/appi.ajp.2016.16020171","volume":"174","author":"S Hafizi","year":"2017","unstructured":"Hafizi S, Tseng H-H, Rao N, Selvanathan T, Kenk M, Bazinet RP et al (2017) Imaging microglial activation in untreated first-episode psychosis: a PET study with [18F]FEPPA. Am J Psychiatry 174:118\u2013124","journal-title":"Am J Psychiatry"},{"key":"5177_CR131","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2016.40","volume":"6","author":"JM Coughlin","year":"2016","unstructured":"Coughlin JM, Wang Y, Ambinder EB, Ward RE, Minn I, Vranesic M et al (2016) In vivo markers of inflammatory response in recent-onset schizophrenia: a combined study using [(11)C]DPA-713 PET and analysis of CSF and plasma. Transl Psychiatry 6:e777","journal-title":"Transl Psychiatry"},{"key":"5177_CR132","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1038\/s41386-018-0061-5","volume":"43","author":"S Hafizi","year":"2018","unstructured":"Hafizi S, Da Silva T, Meyer JH, Kiang M, Houle S, Remington G et al (2018) Interaction between TSPO\u2014a neuroimmune marker\u2014and redox status in clinical high risk for psychosis: a PET\u2013MRS study. Neuropsychopharmacology 43:1700\u20131705","journal-title":"Neuropsychopharmacology"},{"key":"5177_CR133","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1093\/schbul\/sbu157","volume":"41","author":"M Kenk","year":"2014","unstructured":"Kenk M, Selvanathan T, Rao N, Suridjan I, Rusjan P, Remington G et al (2014) Imaging neuroinflammation in gray and white matter in schizophrenia: an in-vivo PET study with [18F]-FEPPA. Schizophr Bull 41:85\u201393","journal-title":"Schizophr Bull"},{"key":"5177_CR134","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1038\/npp.2017.111","volume":"42","author":"S Hafizi","year":"2017","unstructured":"Hafizi S, Da Silva T, Gerritsen C, Kiang M, Bagby RM, Prce I et al (2017) Imaging microglial activation in individuals at clinical high risk for psychosis: an in vivo PET study with [(18)F]FEPPA. Neuropsychopharmacology 42:2474\u20132481","journal-title":"Neuropsychopharmacology"},{"key":"5177_CR135","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.2967\/jnumed.109.066647","volume":"50","author":"J Doorduin","year":"2009","unstructured":"Doorduin J, de Vries EF, Willemsen AT, de Groot JC, Dierckx RA, Klein HC (2009) Neuroinflammation in schizophrenia-related psychosis: a PET study. J Nucl Med 50:1801\u20131807","journal-title":"J Nucl Med"},{"key":"5177_CR136","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.5694\/j.1326-5377.2009.tb02371.x","volume":"190","author":"R Banati","year":"2009","unstructured":"Banati R, Hickie IB (2009) Therapeutic signposts: using biomarkers to guide better treatment of schizophrenia and other psychotic disorders. Med J Aust 190:S26-32","journal-title":"Med J Aust"},{"key":"5177_CR137","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.biopsych.2008.04.025","volume":"64","author":"BN van Berckel","year":"2008","unstructured":"van Berckel BN, Bossong MG, Boellaard R, Kloet R, Schuitemaker A, Caspers E et al (2008) Microglia activation in recent-onset schizophrenia: a quantitative (R)-[11C]PK11195 positron emission tomography study. Biol Psychiatry 64:820\u2013822","journal-title":"Biol Psychiatry"},{"key":"5177_CR138","doi-asserted-by":"crossref","first-page":"5398","DOI":"10.1038\/s41380-020-0829-y","volume":"26","author":"S Conen","year":"2021","unstructured":"Conen S, Gregory CJ, Hinz R, Smallman R, Corsi-Zuelli F, Deakin B et al (2021) Neuroinflammation as measured by positron emission tomography in patients with recent onset and established schizophrenia: implications for immune pathogenesis. Mol Psychiatry 26:5398\u20135406","journal-title":"Mol Psychiatry"},{"key":"5177_CR139","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1017\/S1461145710000313","volume":"13","author":"A Takano","year":"2010","unstructured":"Takano A, Arakawa R, Ito H, Tateno A, Takahashi H, Matsumoto R et al (2010) Peripheral benzodiazepine receptors in patients with chronic schizophrenia: a PET study with [11C]DAA1106. Int J Neuropsychopharmacol 13:943\u2013950","journal-title":"Int J Neuropsychopharmacol"},{"key":"5177_CR140","doi-asserted-by":"crossref","first-page":"16031","DOI":"10.1038\/npjschz.2016.31","volume":"2","author":"TF van der Doef","year":"2016","unstructured":"van der Doef TF, de Witte LD, Sutterland AL, Jobse E, Yaqub M, Boellaard R et al (2016) In vivo (R)-[(11)C]PK11195 PET imaging of 18kDa translocator protein in recent onset psychosis. NPJ Schizophr 2:16031","journal-title":"NPJ Schizophr"},{"key":"5177_CR141","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2017.193","volume":"7","author":"MA Di Biase","year":"2017","unstructured":"Di Biase MA, Zalesky A, O\u2019Keefe G, Laskaris L, Baune BT, Weickert CS et al (2017) PET imaging of putative microglial activation in individuals at ultra-high risk for psychosis, recently diagnosed and chronically ill with schizophrenia. Transl Psychiatry 7:e1225","journal-title":"Transl Psychiatry"},{"key":"5177_CR142","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1038\/mp.2016.180","volume":"21","author":"SE Holmes","year":"2016","unstructured":"Holmes SE, Hinz R, Drake RJ, Gregory CJ, Conen S, Matthews JC et al (2016) In vivo imaging of brain microglial activity in antipsychotic-free and medicated schizophrenia: a [(11)C](R)-PK11195 positron emission tomography study. Mol Psychiatry 21:1672\u20131679","journal-title":"Mol Psychiatry"},{"key":"5177_CR143","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.biopsych.2018.02.1171","volume":"84","author":"P Plav\u00e9n-Sigray","year":"2018","unstructured":"Plav\u00e9n-Sigray P, Matheson GJ, Collste K, Ashok AH, Coughlin JM, Howes OD et al (2018) Positron emission tomography studies of the glial cell marker translocator protein in patients with psychosis: a meta-analysis using individual participant data. Biol Psychiatry 84:433\u2013442","journal-title":"Biol Psychiatry"},{"key":"5177_CR144","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/nrn3229","volume":"13","author":"H Manji","year":"2012","unstructured":"Manji H, Kato T, Di Prospero NA, Ness S, Beal MF, Krams M et al (2012) Impaired mitochondrial function in psychiatric disorders. Nat Rev Neurosci 13:293\u2013307","journal-title":"Nat Rev Neurosci"},{"key":"5177_CR145","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.schres.2017.01.056","volume":"187","author":"RC Roberts","year":"2017","unstructured":"Roberts RC (2017) Postmortem studies on mitochondria in schizophrenia. Schizophr Res 187:17\u201325","journal-title":"Schizophr Res"},{"key":"5177_CR146","doi-asserted-by":"crossref","first-page":"48","DOI":"10.3109\/15622975.2010.505662","volume":"12","author":"SM Somerville","year":"2011","unstructured":"Somerville SM, Conley RR, Roberts RC (2011) Mitochondria in the striatum of subjects with schizophrenia. World J Biol Psychiatry 12:48\u201356","journal-title":"World J Biol Psychiatry"},{"key":"5177_CR147","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1093\/schbul\/sbt070","volume":"39","author":"M Nitta","year":"2013","unstructured":"Nitta M, Kishimoto T, M\u00fcller N, Weiser M, Davidson M, Kane JM et al (2013) Adjunctive use of nonsteroidal anti-inflammatory drugs for schizophrenia: a meta-analytic investigation of randomized controlled trials. Schizophr Bull 39:1230\u20131241","journal-title":"Schizophr Bull"},{"key":"5177_CR148","doi-asserted-by":"crossref","unstructured":"Nozaki K, Ito H, Ohgidani M, Yamawaki Y, Sahin EH, Kitajima T et al (2020) Antidepressant effect of the translocator protein antagonist ONO-2952 on mouse behaviors under chronic social defeat stress. Neuropharmacology 162","DOI":"10.1016\/j.neuropharm.2019.107835"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-025-05177-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-025-05177-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-025-05177-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T11:12:07Z","timestamp":1761909127000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-025-05177-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,4]]},"references-count":148,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["5177"],"URL":"https:\/\/doi.org\/10.1007\/s12035-025-05177-w","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,4]]},"assertion":[{"value":"27 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}